Financial Highlights Second Quarter 2025 Performance The company's Q2 2025 results show improved revenue and a significantly narrowed net loss compared to the prior year | Metric | Q2 2025 (Millions) | Q2 2024 (Millions) | Change (YoY) | | :----- | :----------------- | :----------------- | :----------- | | Revenues | $2,400 | $2,200 | +$200 | | Net Loss | $(165) | $(331) | +$166 (Improvement) | | Loss per Depositary Unit | $(0.30) | $(0.72) | +$0.42 (Improvement) | | Adjusted EBITDA Loss | $(43) | $(155) | +$112 (Improvement) | Six Months Ended June 30, 2025 Performance First-half 2025 performance saw decreased revenues and a wider net loss compared to the same period in 2024 | Metric | YTD 2025 (Millions) | YTD 2024 (Millions) | Change (YoY) | | :----- | :------------------ | :------------------ | :----------- | | Revenues | $4,200 | $4,700 | $(500) | | Net Loss | $(587) | $(369) | $(218) (Worsening) | | Loss per Depositary Unit | $(1.08) | $(0.82) | $(0.26) (Worsening) | | Adjusted EBITDA Loss | $(330) | $(21) | $(309) (Worsening) | Indicative Net Asset Value Update Indicative net asset value increased by $252 million to approximately $3.3 billion during the second quarter of 2025 | Metric | June 30, 2025 (Millions) | March 31, 2025 (Millions) | Change (QoQ) | | :----- | :----------------------- | :------------------------ | :----------- | | Indicative Net Asset Value | $3,300 | $3,048 | +$252 | Quarterly Distribution Declaration A quarterly distribution of $0.50 per depositary unit was declared for Q2 2025 - Distribution Amount: $0.50 per depositary unit45 - Payment Date: On or about September 24, 20254 - Record Date: Close of business on August 18, 20254 - Election Deadline: September 12, 2025, for cash or additional units, with additional units as the default4 Company Information Business Description Icahn Enterprises L.P. is a diversified holding company with subsidiaries in sectors like Investment and Energy - Operating Businesses: Investment, Energy, Automotive, Food Packaging, Real Estate, Home Fashion, and Pharma6 Caution Concerning Forward-Looking Statements The report contains forward-looking statements subject to inherent risks and uncertainties - Forward-looking statements are identified by words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "will" or words of similar meaning7 - Risks include economic downturns, competition, rising operating costs, geopolitical conflicts, investment activities, debt compliance, fair value declines, short sellers, and political/regulatory uncertainty7 - Past performance in the Investment segment is not indicative of future performance, and the company undertakes no obligation to publicly update or review any forward-looking information7 Condensed Consolidated Financial Statements Condensed Consolidated Statements of Operations The statements of operations show improved Q2 2025 revenue but worsened year-to-date revenue and net loss | Metric (Millions) | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 | | :---------------- | :------ | :------ | :------- | :------- | | Net sales | $2,143 | $2,371 | $4,145 | $4,624 | | Other revenues from operations | $172 | $182 | $340 | $356 | | Net loss from investment activities | $(74) | $(479) | $(468) | $(575) | | Interest and dividend income | $69 | $122 | $152 | $265 | | Gain (loss) on disposition of assets, net | $47 | $1 | $44 | $(5) | | Other income, net | $12 | $4 | $23 | $6 | | Total Revenues | $2,369 | $2,201 | $4,236 | $4,671 | | Cost of goods sold | $2,118 | $2,208 | $4,134 | $4,199 | | Other expenses from operations | $154 | $150 | $305 | $299 | | Selling, general and administrative | $207 | $183 | $408 | $376 | | Dividend expense | $7 | $13 | $15 | $33 | | Impairment | $2 | $— | $12 | $— | | Restructuring, net | $(2) | $1 | $5 | $1 | | Interest expense | $129 | $128 | $257 | $264 | | Total Expenses | $2,615 | $2,683 | $5,136 | $5,172 | | Loss before income tax expense | $(246) | $(482) | $(900) | $(501) | | Income tax benefit (expense) | $45 | $(4) | $119 | $(11) | | Net loss | $(201) | $(486) | $(781) | $(512) | | Less: net loss attributable to non-controlling interests | $(36) | $(155) | $(194) | $(143) | | Net loss attributable to Icahn Enterprises | $(165) | $(331) | $(587) | $(369) | | Basic and Diluted loss per LP unit | $(0.30) | $(0.72) | $(1.08) | $(0.82) | | Distributions declared per LP unit | $0.50 | $1.00 | $1.00 | $2.00 | Condensed Consolidated Balance Sheets The balance sheet shows a decrease in total assets and equity as of June 30, 2025, from year-end 2024 | Metric (Millions) | June 30, 2025 | December 31, 2024 | Change | | :---------------- | :------------ | :---------------- | :----- | | Cash and cash equivalents | $1,804 | $2,603 | $(799) | | Cash held at consolidated affiliated partnerships and restricted cash | $2,672 | $2,636 | +$36 | | Investments | $1,972 | $2,310 | $(338) | | Due from brokers | $1,261 | $1,624 | $(363) | | Accounts receivable, net | $420 | $479 | $(59) | | Inventories, net | $905 | $897 | +$8 | | Property, plant and equipment, net | $3,786 | $3,843 | $(57) | | Deferred tax asset | $179 | $160 | +$19 | | Derivative assets, net | $8 | $22 | $(14) | | Goodwill | $290 | $288 | +$2 | | Intangible assets, net | $381 | $409 | $(28) | | Assets held for sale | $25 | $25 | $0 | | Other assets | $1,136 | $983 | +$153 | | Total Assets | $14,839 | $16,279 | $(1,440) | | Accounts payable | $690 | $802 | $(112) | | Accrued expenses and other liabilities | $1,698 | $1,547 | +$151 | | Deferred tax liabilities | $233 | $331 | $(98) | | Derivative liabilities, net | $1,062 | $756 | +$306 | | Securities sold, not yet purchased, at fair value | $996 | $1,373 | $(377) | | Due to brokers | $24 | $40 | $(16) | | Debt | $6,713 | $6,809 | $(96) | | Total Liabilities | $11,416 | $11,658 | $(242) | | Equity attributable to Icahn Enterprises | $1,743 | $2,466 | $(723) | | Equity attributable to non-controlling interests | $1,680 | $2,155 | $(475) | | Total Equity | $3,423 | $4,621 | $(1,198) | | Total Liabilities and Equity | $14,839 | $16,279 | $(1,440) | Non-GAAP Financial Measures & Reconciliation Use of Non-GAAP Financial Measures This section defines EBITDA and Adjusted EBITDA and explains their use and limitations as performance indicators - EBITDA Definition: Earnings from continuing operations before net interest expense (excluding Investment segment), income tax (benefit) expense, and depreciation and amortization12 - Adjusted EBITDA Definition: EBITDA excluding certain effects of impairment, restructuring costs, transformation costs, certain pension plan expenses, and other non-operational charges12 - Rationale for Use: Provides supplemental information for investors and management to evaluate core operating performance and aids in period-to-period and peer comparisons13 - Limitations: These measures do not reflect cash expenditures, do not account for asset replacement, and are not substitutes for U.S. GAAP measures like net income141516 Adjusted EBITDA Reconciliation The reconciliation from net loss to Adjusted EBITDA shows improved Q2 2025 results but a worsened year-to-date figure | Metric (Millions) | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 | | :---------------- | :------ | :------ | :------- | :------- | | Net loss attributable to Icahn Enterprises | $(165) | $(331) | $(587) | $(369) | | Interest expense, net | $88 | $65 | $171 | $128 | | Income tax (benefit) expense | $(30) | $16 | $(86) | $19 | | Depreciation and amortization | $90 | $84 | $169 | $170 | | EBITDA before non-controlling interests | $(17) | $(166) | $(333) | $(52) | | Impairment | $2 | $- | $11 | $- | | Restructuring costs | $(1) | $- | $5 | $- | | (Gain) loss on disposition of assets, net | $(46) | $(1) | $(44) | $4 | | Transformation costs | $12 | $11 | $20 | $22 | | (Gain) loss on extinguishment of debt, net | $(3) | $1 | $(3) | $1 | | Out of period adjustments | $- | $- | $- | $(2) | | Other adjustments | $10 | $- | $14 | $6 | | Adjusted EBITDA attributable to IEP | $(43) | $(155) | $(330) | $(21) | Indicative Net Asset Value Data Explanation of Use This section explains the purpose and limitations of indicative net asset value as a valuation metric - Purpose: Indicative net asset value is an additional method for considering the value of the Company's assets, believed to be helpful to investors17 - Limitations: It does not represent the market price at which depositary units trade, nor are the units redeemable, and it excludes any value for the Investment Segment beyond its fund investments171820 Indicative Net Asset Value Calculation The calculation details the components of the indicative net asset value, including subsidiaries and holding company assets | Component (Millions) | June 30, 2025 | March 31, 2025 | December 31, 2024 | | :------------------- | :------------ | :------------- | :---------------- | | Market-valued Subsidiaries and Investments | | Holding Company interest in Investment Funds | $2,464 | $2,479 | $2,703 | | CVR Energy | $1,891 | $1,330 | $1,250 | | CVR Partners LP | $24 | $16 | $13 | | Total market-valued subsidiaries and investments | $4,379 | $3,825 | $3,966 | | Other Subsidiaries | | Viskase | $71 | $159 | $197 | | Real Estate Segment | $715 | $728 | $743 | | WestPoint Home | $166 | $166 | $162 | | Vivus | $197 | $215 | $209 | | Automotive Services | $442 | $521 | $482 | | Automotive Parts | $- | $3 | $9 | | Automotive Owned Real Estate Assets | $752 | $768 | $768 | | Operating Business Indicative Gross Asset Value | $6,722 | $6,385 | $6,536 | | Add: Other Net Assets | $109 | $(3) | $103 | | Indicative Gross Asset Value | $6,831 | $6,382 | $6,639 | | Add: Holding Company cash and cash equivalents | $1,086 | $1,318 | $1,397 | | Less: Holding Company debt | $(4,664) | $(4,699) | $(4,699) | | Indicative Net Asset Value | $3,253 | $3,001 | $3,337 | Investor Contact Information Contact Details This section provides contact information for investor inquiries - Contact Person: Ted Papapostolou, Chief Financial Officer23 - Email: IR@ielp.com23 - Phone: (800) 255-273723
Icahn Enterprises(IEP) - 2025 Q2 - Quarterly Results